This Small Business Innovation Research (SBIR) grant is designed to support small business concerns (SBCs) in developing groundbreaking technologies for Type 1 Diabetes (T1D). The primary purpose is to fund research that advances methods for the early detection and comprehensive assessment of individuals at risk for T1D. It also seeks innovations for early diagnosis, accurate prognosis, and effective follow-up of the disease. The ultimate goal is to enable earlier interventions, thereby preventing acute complications at diagnosis and delaying the onset of clinical manifestations and long-term complications associated with T1D. This initiative aims to significantly improve patient outcomes through innovative technological solutions.
Opportunity ID: 334347
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-21-021 |
| Funding Opportunity Title: | Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 25, 2021 |
| Last Updated Date: | Jun 25, 2021 |
| Original Closing Date for Applications: | Oct 07, 2022 |
| Current Closing Date for Applications: | Oct 07, 2022 |
| Archive Date: | Nov 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D) to avoid acute complications at diagnosis and to allow earlier interventions to prevent and/or delay clinical manifestations and long term complications of the disease. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-021.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334347 Full Announcement-RFA-DK-21-021 -> RFA-DK-21-021-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00267922 | Jan 17, 2022 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270958 | Jan 17, 2022 | Oct 07, 2022 | View |
Package 1
Mandatory forms
334347 RR_SF424_2_0-2.0.pdf
334347 PHS398_CoverPageSupplement_5_0-5.0.pdf
334347 RR_OtherProjectInfo_1_4-1.4.pdf
334347 PerformanceSite_2_0-2.0.pdf
334347 RR_KeyPersonExpanded_2_0-2.0.pdf
334347 RR_Budget_1_4-1.4.pdf
334347 PHS398_ResearchPlan_4_0-4.0.pdf
334347 SBIR_STTR_Information_1_3-1.3.pdf
334347 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334347 RR_SubawardBudget30_1_4-1.4.pdf
334347 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334347 RR_SF424_5_0-5.0.pdf
334347 PHS398_CoverPageSupplement_5_0-5.0.pdf
334347 RR_OtherProjectInfo_1_4-1.4.pdf
334347 PerformanceSite_4_0-4.0.pdf
334347 RR_KeyPersonExpanded_4_0-4.0.pdf
334347 RR_Budget_3_0-3.0.pdf
334347 PHS398_ResearchPlan_4_0-4.0.pdf
334347 SBIR_STTR_Information_3_0-3.0.pdf
334347 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334347 RR_SubawardBudget30_3_0-3.0.pdf
334347 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
